The worst drug rule revisited: mathematical modeling of cyclic cancer treatments

DOI10.1007/S11538-010-9539-YMaRDI QIDQ644401zbMATH OpenOpenAlexWikidataFDO

Authors Allen A. Katouli, Natalia L. Komarova

Publication date 4 November 2011

Published in Bulletin of Mathematical Biology (Search for Journal in Brave)

Copyright license Creative Commons Attribution-NonCommercial 4.0 International

Full work available at URL https://doi.org/10.1007/s11538-010-9539-y

zbMATH Keywords

CMLstochastic modeling of cancer

Mathematics Subject Classification ID

Medical applications (general) (92C50) Applications of branching processes (60J85) Miscellaneous topics in calculus of variations and optimal control (49N99)

Recommendations

• scientific article; zbMATH DE number 1114142
• scientific article; zbMATH DE number 1343152
• Mathematical modeling of cyclic treatments of chronic myeloid leukemia
• Drug resistance in cancer chemotherapy as an optimal control problem
• Optimal therapy scheduling based on a pair of collaterally sensitive drugs

Cites work

• scientific article; zbMATH DE number 2150813 (Why is no real title available?)
• scientific article; zbMATH DE number 3206712 (Why is no real title available?)
• A branching-process model for heterogeneous cell populations
• A model for the resistance of tumor cells to cancer chemotherapeutic agents
• A stochastic model for the origin and treatment of tumors containing drug-resistant cells
• Cancer Modelling and Simulation
• Handbook of stochastic methods for physics, chemistry and the natural sciences.
• ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
• Selected topics in cancer modeling. Genesis, evolution, immune competition, and therapy
• The fixed-size Luria-Delbrück model with a nonzero death rate
• The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics

Cited in

(8)

• The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
• Theoretical modeling of collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy
• On probabilistic certification of combined cancer therapies using strongly uncertain models
• Optimal therapy scheduling based on a pair of collaterally sensitive drugs
• Mathematical modeling of cyclic treatments of chronic myeloid leukemia
• Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model
• Modeling the role of altruism of antibiotic-resistant bacteria
• A branching process model of heterogeneous DNA damages caused by radiotherapy in \textit{in vitro} cell cultures

This page was built for publication: The worst drug rule revisited: mathematical modeling of cyclic cancer treatments

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q644401)